Sivik Global Healthcare’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-40,000
Closed -$2.65M 44
2022
Q1
$2.65M Buy
40,000
+15,000
+60% +$1.03M 1.09% 42
2021
Q4
$2.5M Buy
+25,000
New +$2.59M 1.07% 38
2021
Q2
Sell
-10,000
Closed -$1.53M 54
2021
Q1
$1.53M Sell
10,000
-35,000
-78% -$5.29M 0.56% 45
2020
Q4
$5.8M Buy
45,000
+10,000
+29% +$1.15M 2.36% 25
2020
Q3
$3.91M Buy
+35,000
New +$3.2M 1.68% 30

Other funds holding GH

Sivik Global Healthcare's GH Position: Q2 2022 in Review

Sivik Global Healthcare sold out of Guardant Health (GH) in Q2 2022, closing a stake of 40,000 shares — an estimated $2.65M sold.

Sivik Global Healthcare first reported a position in GH in Q3 2020 and held it in 5 quarters. The position peaked at $5.8M in Q4 2020. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Sivik Global Healthcare reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Sivik Global Healthcare sold 40,000 Guardant Health shares in Q2 2022, an estimated $2.65M.
  • Sivik Global Healthcare first reported a position in Guardant Health in Q3 2020 and held it in 5 quarters.
  • Sivik Global Healthcare's Guardant Health position peaked at $5.8M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Sivik Global Healthcare's 13F filing for Q2 2022, filed 10 Aug 2022.